Arcutis Biotherapeutics, Inc. ARQT Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Arcutis Biotherapeutics, Inc. (ARQT) reported increase (decrease) in prepaid expense and other assets of $11.73M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets increased by 257.3% year-over-year, from $3.28M to $11.73M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -24.0% compound annual growth rate (CAGR), from -$3.47M to $2.01M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.